The Community Guide

- gsearch

Search Results

Narrow Results:

Charla Informativa 3
Toolbox Talk 3

1 - 20 of 181 Results

Refine Results

Refine Results:

Frequently asked questions about coronavirus (COVID-19) for laboratories

CITE Title : Frequently asked questions about coronavirus (COVID-19) for laboratories Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Oct. 25, 2021 URL : https://stacks.cdc.gov/view/cdc/111102 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). Frequently asked questions about coronavirus (COVID-19) for laboratories. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Frequently asked questions about coronavirus (COVID-19) for laboratories" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Frequently asked questions about coronavirus (COVID-19) for laboratories" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Oct. 25, 2021

No Description
Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)

CITE Title : Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19) Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Oct. 28, 2021 URL : https://stacks.cdc.gov/view/cdc/111111 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19). National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Oct. 28, 2021

:

Updated Oct. 28, 2021
2020 Federal Select Agent Program Inspection Report Processing annual summary

CITE Title : 2020 Federal Select Agent Program Inspection Report Processing annual summary Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.);Center for Preparedness and Response (U.S.). Division of Select Agents and Toxins.;United States. Animal and Plant Health Inspection Service. Agriculture Select Agent Program.; Published Date : August, 2021 Pages in Document : 8 numbered pages URL : https://stacks.cdc.gov/view/cdc/111004 Centers for Disease Control and Prevention (U.S.) (2021). 2020 Federal Select Agent Program Inspection Report Processing annual summary. Centers for Disease Control and Prevention (U.S.) "2020 Federal Select Agent Program Inspection Report Processing annual summary" (2021) Centers for Disease Control and Prevention (U.S.) "2020 Federal Select Agent Program Inspection Report Processing annual summary" , 2021 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.) ...

August, 2021

:

The 2020 Federal Select Agent Program (FSAP) Inspection Report Processing AnnualSummary presents an analysis of FSAP’s responsiveness in providing f...
Biological risk assessment : general considerations for laboratories

CITE Title : Biological risk assessment : general considerations for laboratories Corporate Authors(s) : Center for Surveillance, Epidemiology and Laboratory Services (U.S.). Division of Laboratory Systems. Published Date : March 31, 2021 URL : https://stacks.cdc.gov/view/cdc/106795 Center for Surveillance, Epidemiology and Laboratory Services (U.S.). Division of Laboratory Systems. (2021). Biological risk assessment : general considerations for laboratories. Center for Surveillance, Epidemiology and Laboratory Services (U.S.). Division of Laboratory Systems. "Biological risk assessment : general considerations for laboratories" (2021) Center for Surveillance, Epidemiology and Laboratory Services (U.S.). Division of Laboratory Systems. "Biological risk assessment : general considerations for laboratories" , 2021 Export RIS Citation Information.

:

Center for Surveillance, Epidemiology and Laboratory Services (U.S.). Division of Laboratory Systems.

March 31, 2021

:

CDC’s Division of Laboratory Systems knows that incidents involving biological, chemical, physical, and radiological hazards can have a significant ...
Coronavirus disease 2019 (COVID-19) : frequently asked questions

CITE Title : Coronavirus disease 2019 (COVID-19) : frequently asked questions Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Mar 17, 2021 Series : Coronavirus Disease 2019 (CoVID-19) URL : https://stacks.cdc.gov/view/cdc/104220 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). Coronavirus disease 2019 (COVID-19) : frequently asked questions. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Coronavirus disease 2019 (COVID-19) : frequently asked questions" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Coronavirus disease 2019 (COVID-19) : frequently asked questions" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Mar 17, 2021 | Coronavirus Disease 2019 (CoVID-19)

:

Updated Mar. 17, 2021
Frequently asked questions about coronavirus (COVID-19) for laboratories

CITE Title : Frequently asked questions about coronavirus (COVID-19) for laboratories Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : 03/10/2021 URL : https://stacks.cdc.gov/view/cdc/104168 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). Frequently asked questions about coronavirus (COVID-19) for laboratories. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Frequently asked questions about coronavirus (COVID-19) for laboratories" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Frequently asked questions about coronavirus (COVID-19) for laboratories" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

03/10/2021

:

Updated Mar. 10, 2021
Interim guidelines for collecting, handling, and testing clinical specimens for COVID-19 : interim guidelines for collecting, handling, and testing clinical specimens from persons for coronavirus disease 2019 (COVID-19)

CITE Title : Interim guidelines for collecting, handling, and testing clinical specimens for COVID-19 : interim guidelines for collecting, handling, and testing clinical specimens from persons for coronavirus disease 2019 (COVID-19) Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Feb 26, 2021 URL : https://stacks.cdc.gov/view/cdc/104491 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2021). Interim guidelines for collecting, handling, and testing clinical specimens for COVID-19 : interim guidelines for collecting, handling, and testing clinical specimens from persons for coronavirus disease 2019 (COVID-19). National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim guidelines for collecting, handling, and testing clinical specimens for COVID-19 : interim guidelines for collecting, handling, and testing clinical specimens from persons for coronavirus disease 2019 (COVID-19)" (2021) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim guidelines for collecting, handling, and testing clinical specimens for COVID-19 : interim guidelines for collecting, handling, and testing clinical specimens from persons for coronavirus disease 2019 (COVID-19)" , 2021 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Feb 26, 2021

:

Updated Feb. 26, 2021• The type of specimen collected when testing for current or past infection with SARS-CoV-2 is based on the test being performe...
Frequently asked questions about coronavirus (COVID-19) for laboratories

CITE Title : Frequently asked questions about coronavirus (COVID-19) for laboratories Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : July 16, 2020 Series : Coronavirus Disease 2019 (CoVID-19) URL : https://stacks.cdc.gov/view/cdc/90657 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2020). Frequently asked questions about coronavirus (COVID-19) for laboratories. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Frequently asked questions about coronavirus (COVID-19) for laboratories" (2020) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Frequently asked questions about coronavirus (COVID-19) for laboratories" , 2020 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

July 16, 2020 | Coronavirus Disease 2019 (CoVID-19)

:

Updated July 16, 2020
Frequently asked questions about coronavirus (COVID-19) for laboratories

CITE Title : Frequently asked questions about coronavirus (COVID-19) for laboratories Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : July 23, 2020 Series : Coronavirus Disease 2019 (CoVID-19) URL : https://stacks.cdc.gov/view/cdc/90939 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2020). Frequently asked questions about coronavirus (COVID-19) for laboratories. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Frequently asked questions about coronavirus (COVID-19) for laboratories" (2020) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Frequently asked questions about coronavirus (COVID-19) for laboratories" , 2020 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

July 23, 2020 | Coronavirus Disease 2019 (CoVID-19)

:

Updated July 23, 2020
Interim guidelines for biosafety and COVID-19 : interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)

CITE Title : Interim guidelines for biosafety and COVID-19 : interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19) Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : July 18, 2020 Series : Coronavirus Disease 2019 (CoVID-19) URL : https://stacks.cdc.gov/view/cdc/90926 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2020). Interim guidelines for biosafety and COVID-19 : interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19). National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim guidelines for biosafety and COVID-19 : interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)" (2020) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Interim guidelines for biosafety and COVID-19 : interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)" , 2020 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

July 18, 2020 | Coronavirus Disease 2019 (CoVID-19)

:

Updated July 18, 202Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SA...
Frequently asked questions about biosafety and COVID-19

CITE Title : Frequently asked questions about biosafety and COVID-19 Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : May 11, 2020 Series : Coronavirus Disease 2019 (CoVID-19) URL : https://stacks.cdc.gov/view/cdc/88178 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2020). Frequently asked questions about biosafety and COVID-19. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Frequently asked questions about biosafety and COVID-19" (2020) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Frequently asked questions about biosafety and COVID-19" , 2020 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

May 11, 2020 | Coronavirus Disease 2019 (CoVID-19)

:

Updated May 11, 2020
Interim laboratory biosafety guidelines for handling and processing specimens associated with severe acute respiratory syndrome (SARS)

CITE Title : Interim laboratory biosafety guidelines for handling and processing specimens associated with severe acute respiratory syndrome (SARS) Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : April 2, 2003 Pages in Document : 2 numbered pages Source : Severe acute respiratory syndrome URL : https://stacks.cdc.gov/view/cdc/24824 Centers for Disease Control and Prevention (U.S.) (2003). Interim laboratory biosafety guidelines for handling and processing specimens associated with severe acute respiratory syndrome (SARS). Centers for Disease Control and Prevention (U.S.) "Interim laboratory biosafety guidelines for handling and processing specimens associated with severe acute respiratory syndrome (SARS)" (2003) Centers for Disease Control and Prevention (U.S.) "Interim laboratory biosafety guidelines for handling and processing specimens associated with severe acute respiratory syndrome (SARS)" , 2003 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

April 2, 2003 | Severe acute respiratory syndrome

:

The Centers for Disease Control and Prevention (CDC) and the World Health Organization have received reports of patients with Severe Acute Respiratory...
Laboratory biosafety guidelines for handling and processing specimens associated with SARS-CoV

CITE Title : Laboratory biosafety guidelines for handling and processing specimens associated with SARS-CoV Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : January 8, 2004 Pages in Document : 3 numbered pages Source : Severe acute respiratory syndrome;Public health guidance for community-level preparedness and response to severe acute respiratory syndrome (SARS) Version 2. Supplement F: Laboratory guidance appendix F5; URL : https://stacks.cdc.gov/view/cdc/24825 Centers for Disease Control and Prevention (U.S.) (2004). Laboratory biosafety guidelines for handling and processing specimens associated with SARS-CoV. Centers for Disease Control and Prevention (U.S.) "Laboratory biosafety guidelines for handling and processing specimens associated with SARS-CoV" (2004) Centers for Disease Control and Prevention (U.S.) "Laboratory biosafety guidelines for handling and processing specimens associated with SARS-CoV" , 2004 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)

January 8, 2004 | Severe acute respiratory syndrome;

:

Although routine clinical laboratories around the world have processed an estimated several thousand diagnostic specimens from patients with SARS, no ...
Enhancing domestic laboratory biosafety for Ebola and other highly infectious diseases

CITE Title : Enhancing domestic laboratory biosafety for Ebola and other highly infectious diseases Personal Author(s) : Merlin, Toby L. Corporate Authors(s) : National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Preparedness and Emerging Infections.;Centers for Disease Control and Prevention (U.S.). Clinical Laboratory Improvement Advisory Committee.; Conference Author(s) : Clinical Laboratory Improvement Advisory Committee. Meeting (2016 April 13-14 : Atlanta, GA) Published Date : 4/5/16 Pages in Document : 18 unnumbered slides URL : https://stacks.cdc.gov/view/cdc/46542 Merlin, Toby L. (2016). Enhancing domestic laboratory biosafety for Ebola and other highly infectious diseases. Merlin, Toby L. "Enhancing domestic laboratory biosafety for Ebola and other highly infectious diseases" (2016) Merlin, Toby L. "Enhancing domestic laboratory biosafety for Ebola and other highly infectious diseases" , 2016 Export RIS Citation Information.

:

Merlin, Toby L.

4/5/16

:

Slides from a presentation given at the CLIAC meeting, April 14, 2016.Publication date from document properties.9_Merlin_Biosafety_CLIAC_April2016.pdf
Frequently asked questions about coronavirus (COVID-19) for laboratories

CITE Title : Frequently asked questions about coronavirus (COVID-19) for laboratories Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : Aug. 15, 2020 URL : https://stacks.cdc.gov/view/cdc/92020 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2020). Frequently asked questions about coronavirus (COVID-19) for laboratories. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Frequently asked questions about coronavirus (COVID-19) for laboratories" (2020) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Frequently asked questions about coronavirus (COVID-19) for laboratories" , 2020 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Aug. 15, 2020

:

Updated Aug. 15, 2020
Frequently asked questions about coronavirus (COVID-19) for laboratories

CITE Title : Frequently asked questions about coronavirus (COVID-19) for laboratories Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : July 29, 2020 Series : Coronavirus Disease 2019 (CoVID-19) URL : https://stacks.cdc.gov/view/cdc/91229 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2020). Frequently asked questions about coronavirus (COVID-19) for laboratories. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Frequently asked questions about coronavirus (COVID-19) for laboratories" (2020) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Frequently asked questions about coronavirus (COVID-19) for laboratories" , 2020 Export RIS Citation Information.

:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

July 29, 2020 | Coronavirus Disease 2019 (CoVID-19)

:

Updated July 29, 2020
Federal Select Agent Progam 2018 annual report : key statistics

CITE Title : Federal Select Agent Progam 2018 annual report : key statistics Corporate Authors(s) : Centers for Disease Control and Prevention (U.S). Center for Preparedness and Response. Division of Select Agents and Toxins.;United States. Animal and Plant Health Inspection Service. Agriculture Select Agent Program.; Published Date : 1/13/20 Pages in Document : 1 poster URL : https://stacks.cdc.gov/view/cdc/84543 Centers for Disease Control and Prevention (U.S). Center for Preparedness and Response. Division of Select Agents and Toxins. (2020). Federal Select Agent Progam 2018 annual report : key statistics. Centers for Disease Control and Prevention (U.S). Center for Preparedness and Response. Division of Select Agents and Toxins. "Federal Select Agent Progam 2018 annual report : key statistics" (2020) Centers for Disease Control and Prevention (U.S). Center for Preparedness and Response. Division of Select Agents and Toxins. "Federal Select Agent Progam 2018 annual report : key statistics" , 2020 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S). Center for Preparedness and Response. Division of Select Agents and Toxins. ...

1/13/20

:

The 2018 Annual Report of the Federal Select Agent Program continues to provide insight into the regulatory activities of the Federal Select Agent Pro...
2018 Annual report of the Federal Select Agent Program

CITE Title : 2018 Annual report of the Federal Select Agent Program Corporate Authors(s) : Centers for Disease Control and Prevention (U.S). Center for Preparedness and Response. Division of Select Agents and Toxins.;United States. Animal and Plant Health Inspection Service. Agriculture Select Agent Program.; Published Date : 1/14/20 Pages in Document : 28 numbered pages URL : https://stacks.cdc.gov/view/cdc/84466 Centers for Disease Control and Prevention (U.S). Center for Preparedness and Response. Division of Select Agents and Toxins. (2020). 2018 Annual report of the Federal Select Agent Program. Centers for Disease Control and Prevention (U.S). Center for Preparedness and Response. Division of Select Agents and Toxins. "2018 Annual report of the Federal Select Agent Program" (2020) Centers for Disease Control and Prevention (U.S). Center for Preparedness and Response. Division of Select Agents and Toxins. "2018 Annual report of the Federal Select Agent Program" , 2020 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S). Center for Preparedness and Response. Division of Select Agents and Toxins. ...

1/14/20

:

The Federal Select Agent Program regulates the possession, use, and transfer of biological select agents and toxins that have the potential to pose a ...
Guidance on the inactivation or removal of select agents and toxins for future use (7 CFR Part 331, 9 CFR Part 121.3, 42 CFR Part 73.3)

CITE Title : Guidance on the inactivation or removal of select agents and toxins for future use (7 CFR Part 331, 9 CFR Part 121.3, 42 CFR Part 73.3) Corporate Authors(s) : Centers for Disease Control and Prevention (U.S). Office of Public Health Preparedness and Response. Division of Select Agents and Toxins.;United States. Animal and Plant Health Inspection Service. Agriculture Select Agent Program.; Published Date : August 2017 Pages in Document : 20 numbered pages URL : https://stacks.cdc.gov/view/cdc/61478 Centers for Disease Control and Prevention (U.S). Office of Public Health Preparedness and Response. Division of Select Agents and Toxins. (2017). Guidance on the inactivation or removal of select agents and toxins for future use (7 CFR Part 331, 9 CFR Part 121.3, 42 CFR Part 73.3). Centers for Disease Control and Prevention (U.S). Office of Public Health Preparedness and Response. Division of Select Agents and Toxins. "Guidance on the inactivation or removal of select agents and toxins for future use (7 CFR Part 331, 9 CFR Part 121.3, 42 CFR Part 73.3)" (2017) Centers for Disease Control and Prevention (U.S). Office of Public Health Preparedness and Response. Division of Select Agents and Toxins. "Guidance on the inactivation or removal of select agents and toxins for future use (7 CFR Part 331, 9 CFR Part 121.3, 42 CFR Part 73.3)" , 2017 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S). Office of Public Health Preparedness and Response. Division of Select Agents and Toxins. ...

August 2017

:

The United States Department of Health and Human Services (HHS) and the United States Department of Agriculture (USDA) have established regulatory req...
2016 Annual report of the Federal Select Agent Program

CITE Title : 2016 Annual report of the Federal Select Agent Program Corporate Authors(s) : Centers for Disease Control and Prevention (U.S). Office of Public Health Preparedness and Response. Division of Select Agents and Toxins;United States. Animal and Plant Health Inspection Service. Agriculture Select Agent Program.; Published Date : 10/25/17 Pages in Document : 30 numbered pages URL : https://stacks.cdc.gov/view/cdc/61300 Centers for Disease Control and Prevention (U.S). Office of Public Health Preparedness and Response. Division of Select Agents and Toxins (2017). 2016 Annual report of the Federal Select Agent Program. Centers for Disease Control and Prevention (U.S). Office of Public Health Preparedness and Response. Division of Select Agents and Toxins "2016 Annual report of the Federal Select Agent Program" (2017) Centers for Disease Control and Prevention (U.S). Office of Public Health Preparedness and Response. Division of Select Agents and Toxins "2016 Annual report of the Federal Select Agent Program" , 2017 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S). Office of Public Health Preparedness and Response. Division of Select Agents and Toxins ...

10/25/17

:

The Federal Select Agent Program (FSAP) is managed jointly by the Department of Health and Human Services (HHS), Centers for Disease Control and Preve...

1 - 20 / 181

1 2 3 4 ... 10